When was Cost Plus Drug founded?

Cost Plus Drug was founded in 2016.

Where is Cost Plus Drug located?

Cost Plus Drug is headquartered in Dallas, United States.

How many employees does Cost Plus Drug have?

As of Jul 01, 2024, the latest employee count at Cost Plus Drug is 11.

Is Cost Plus Drug a funded company?

Cost Plus Drug is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Cost Plus Drug rank among its competitors?

Cost Plus Drug ranks 2nd amongst 55 active competitors, of which 3 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Pfizer, which secured $117M in Jun, 2023.

Who are the top competitors of Cost Plus Drug?

Cost Plus Drug's top competitors include Pfizer, Lovell Government Services and Aurobindo Pharma USA. Among them, Pfizer secured the most recent funding round in June, 2023.

Cost Plus Drug - 2026 Company Profile, Team & Competitors

Cost Plus Drug is an unfunded company based in Dallas (United States), founded in 2016 by Alex Oshmyansky and Mark Cuban. It operates as a Distributor of generic drugs. Cost Plus Drug has not raised any funding yet. The company has 55 active competitors, including 3 funded and 10 that have exited. Its top competitors include companies like Pfizer, Lovell Government Services and Aurobindo Pharma USA.

Company Details

Website: costplusdrugs.com
Social
Email ID: *****@costplusdrugs.com, *****@costplusdrugs.com

Key Metrics

Founded Year

2016

Location

Dallas, United States

Stage

Unfunded

Ranked

2^nd among 55 active competitors

Employee Count

11 as on Jul 01, 2024

Similar Companies

Pfizer & 446 more

View Cost Plus Drug's full profile

Cost Plus Drug has not raised any funding rounds yet.

The founders of Cost Plus Drug are Alex Oshmyansky and Mark Cuban.

Here are the details of Cost Plus Drug's key team members:

Alex Oshmyansky: Co-Founder of Cost Plus Drug. They are also an angel investor in 1 startup.
Contact Info: 1 email address
Mark Cuban: Co-Founder of Cost Plus Drug. They are also an angel investor in 1 startup.
Contact Info: 1 email address

View details of Cost Plus Drug's Founder profiles and Board Members

Cost Plus Drug's employee count trend

Cost Plus Drug has 11 employees as of Jul 24. Here is Cost Plus Drug's employee count trend over the years:

Uncover Cost Plus Drug's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cost Plus Drug include Pfizer, Lovell Government Services and Aurobindo Pharma USA. Here is the list of Top 10 competitors of Cost Plus Drug, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Pfizer 1849, New York City (United States), Public	Provider of pharmaceutical products for multiple disease treatments	-	Alcor Fund, Benson Family Private Equity ... & 16 others	77/100
2nd	Cost Plus Drug 2016, Dallas (United States), Unfunded	Distributor of generic drugs	-	-	43/100
3rd	Lovell Government Services 2013, Pensacola (United States), Unfunded	Distributor of pharmaceutical products	-	-	40/100
4th	Aurobindo Pharma USA 1994, East Windsor (United States), Unfunded	Distributor of generic drugs	-	-	35/100
5th	KeySource 1996, Cincinnati (United States), Acquired	Distributor of pharmaceutical products	-	HEPCO Capital Management	32/100
6th	Auburn 1993, Rochester Hills (United States), Unfunded	Wholesaler distributes generic drugs purchased directly from manufacturers to pharmacies	-	-	28/100
7th	Bayshore Pharmaceuticals 2011, Short Hills (United States), Acquired	Manufacturer of pharmaceutical products	-	-	27/100
8th	Red Oak Sourcing 2014, Foxborough (United States), Seed	Distributor of generic drugs	$2.1M	-	26/100
9th	Peli BioThermal 2003, Maple Grove (United States), Unfunded	Provider of generic drugs distribution and packaging services	-	-	26/100
10th	AF Hauser 1983, Valparaiso (United States), Acquired	Distributor of generic pharmaceutical drugs	-	-	25/100